205 related articles for article (PubMed ID: 16569345)
1. c-MYC deregulation is involved in melphalan resistance of multiple myeloma: role of PDGF-BB.
Greco C; D'Agnano I; Vitelli G; Vona R; Marino M; Mottolese M; Zuppi C; Capoluongo E; Ameglio F
Int J Immunopathol Pharmacol; 2006; 19(1):67-79. PubMed ID: 16569345
[TBL] [Abstract][Full Text] [Related]
2. Increased sensitivity to the platelet-derived growth factor (PDGF) receptor inhibitor STI571 in chemoresistant glioma cells is associated with enhanced PDGF-BB-mediated signaling and STI571-induced Akt inactivation.
Servidei T; Riccardi A; Sanguinetti M; Dominici C; Riccardi R
J Cell Physiol; 2006 Jul; 208(1):220-8. PubMed ID: 16575905
[TBL] [Abstract][Full Text] [Related]
3. Glutathione depletion induced by c-Myc downregulation triggers apoptosis on treatment with alkylating agents.
Biroccio A; Benassi B; Fiorentino F; Zupi G
Neoplasia; 2004; 6(3):195-206. PubMed ID: 15153331
[TBL] [Abstract][Full Text] [Related]
4. Additive effects of hyperbaric oxygen and platelet-derived growth factor-BB in chondrocyte transplantation via up-regulation expression of platelet-derived growth factor-beta receptor.
Yuan LJ; Niu CC; Lin SS; Chan YS; Yang CY; Chen WJ; Ueng SW
J Orthop Res; 2009 Nov; 27(11):1439-46. PubMed ID: 19402136
[TBL] [Abstract][Full Text] [Related]
5. Experimental study enhancing the chemosensitivity of multiple myeloma to melphalan by using a tissue-specific APE1-silencing RNA expression vector.
Yang ZZ; Chen XH; Wang D
Clin Lymphoma Myeloma; 2007 Jan; 7(4):296-304. PubMed ID: 17324338
[TBL] [Abstract][Full Text] [Related]
6. [Observations on expression of c-fos and c-myc genes and activity of PDGFBB autocrine loop in 67 human gliomas].
Yu S; Pu P; Jiang D; Cheng Y; An T; Guan X
Zhonghua Bing Li Xue Za Zhi; 1999 Jun; 28(3):182-6. PubMed ID: 11869525
[TBL] [Abstract][Full Text] [Related]
7. Calcitriol inhibits growth response to Platelet-Derived Growth Factor-BB in human prostate cells.
Nazarova N; Golovko O; Bläuer M; Tuohimaa P
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):189-96. PubMed ID: 15862965
[TBL] [Abstract][Full Text] [Related]
8. An inverse switch in DNA base excision and strand break repair contributes to melphalan resistance in multiple myeloma cells.
Sousa MM; Zub KA; Aas PA; Hanssen-Bauer A; Demirovic A; Sarno A; Tian E; Liabakk NB; Slupphaug G
PLoS One; 2013; 8(2):e55493. PubMed ID: 23405159
[TBL] [Abstract][Full Text] [Related]
9. Effects of KTJ740, a novel antithrombotic agent, on platelet-derived growth factor-induced rat aortic smooth muscle cell proliferation and cell cycle progression.
Kim TJ; Jeon J; Jin YR; Son DJ; Yoo HS; Hong JT; Ryu CK; Shin HS; Lee KH; Yun YP
J Cardiovasc Pharmacol; 2007 May; 49(5):280-6. PubMed ID: 17513946
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of DEPTOR inhibits cell proliferation and increases chemosensitivity to melphalan in human multiple myeloma RPMI-8226 cells via inhibiting PI3K/AKT activity.
Zhang HR; Chen JM; Zeng ZY; Que WZ
J Int Med Res; 2013 Jun; 41(3):584-95. PubMed ID: 23613505
[TBL] [Abstract][Full Text] [Related]
11. Genotypic and phenotypic comparisons of de novo and acquired melphalan resistance in an isogenic multiple myeloma cell line model.
Hazlehurst LA; Enkemann SA; Beam CA; Argilagos RF; Painter J; Shain KH; Saporta S; Boulware D; Moscinski L; Alsina M; Dalton WS
Cancer Res; 2003 Nov; 63(22):7900-6. PubMed ID: 14633719
[TBL] [Abstract][Full Text] [Related]
12. [Anti-angiogenesis effect of metronomic chemotherapy in multiple myeloma patients].
Guo LP; Zhou F; Wei W; Zhang YZ; Shi HT; Lin CH; Li L; Hou J
Zhonghua Xue Ye Xue Za Zhi; 2012 Jun; 33(6):457-60. PubMed ID: 22967380
[TBL] [Abstract][Full Text] [Related]
13. Embryonic mouse testis development: role of platelet derived growth factor (PDGF-BB).
Ricci G; Catizone A; Galdieri M
J Cell Physiol; 2004 Sep; 200(3):458-67. PubMed ID: 15254974
[TBL] [Abstract][Full Text] [Related]
14. Platelet-derived growth factor expression and stimulation in human meningiomas.
Black PM; Carroll R; Glowacka D; Riley K; Dashner K
J Neurosurg; 1994 Sep; 81(3):388-93. PubMed ID: 8057146
[TBL] [Abstract][Full Text] [Related]
15. Schwann cell lines derived from malignant peripheral nerve sheath tumors respond abnormally to platelet-derived growth factor-BB.
Dang I; DeVries GH
J Neurosci Res; 2005 Feb; 79(3):318-28. PubMed ID: 15602756
[TBL] [Abstract][Full Text] [Related]
16. Bcl-2 overexpression is associated with resistance to dexamethasone, but not melphalan, in multiple myeloma cells.
Gazitt Y; Fey V; Thomas C; Alvarez R
Int J Oncol; 1998 Aug; 13(2):397-405. PubMed ID: 9664139
[TBL] [Abstract][Full Text] [Related]
17. Characterization of platelet-derived growth factor (PDGF) action on a mouse neuroblastoma cell line, NB41, by introduction of an antisense PDGF beta-receptor RNA.
Funa K; Ahgren A
Cell Growth Differ; 1997 Aug; 8(8):861-9. PubMed ID: 9269895
[TBL] [Abstract][Full Text] [Related]
18. Platelet-derived growth factor-B gene delivery sustains gingival fibroblast signal transduction.
Lin Z; Sugai JV; Jin Q; Chandler LA; Giannobile WV
J Periodontal Res; 2008 Aug; 43(4):440-9. PubMed ID: 18823454
[TBL] [Abstract][Full Text] [Related]
19. Chemosensitization by STI571 targeting the platelet-derived growth factor/platelet-derived growth factor receptor-signaling pathway in the tumor progression and angiogenesis of gastric carcinoma.
Kim R; Emi M; Arihiro K; Tanabe K; Uchida Y; Toge T
Cancer; 2005 May; 103(9):1800-9. PubMed ID: 15786421
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of CD98 in melphalan-resistant myeloma cells with reduced drug uptake.
Harada N; Nagasaki A; Hata H; Matsuzaki H; Matsuno F; Mitsuya H
Acta Haematol; 2000; 103(3):144-51. PubMed ID: 10940652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
